ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Five Advocates Named To SWOG Committees; NCI, NASA Sign Nanotechnology Agreement.

April 21, 2000

Revised Guidelines For Core, Exploratory Grants Available

March 5, 1976

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993

NCI-Approved Clinical Trials

September 29, 2006

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008